Fischer Medical Ventures Limited
Fischer Medical Ventures Limited (FISCHER) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies
fischermv.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21 Cr | 10 Cr | 40 Cr | 12 Cr | 49 Cr | 23 Cr | 86 Cr | 101 Cr | 98 Cr | 82 Cr |
| Operating expenses (approx.) | 18 Cr | 10 Cr | 39 Cr | 11 Cr | 47 Cr | 19 Cr | 70 Cr | 80 Cr | 97 Cr | 71 Cr |
| EBITDA | 3 Cr | -0.18 Cr | 0.49 Cr | 0.50 Cr | 3 Cr | 4 Cr | 16 Cr | 22 Cr | 1 Cr | 11 Cr |
| OPM % | 12.1% | -1.7% | 1.2% | 4.2% | 5.1% | 18.2% | 18.8% | 21.3% | 1.0% | 13.7% |
| Other income | 0.47 Cr | 0.74 Cr | 0.22 Cr | 0.38 Cr | 0.15 Cr | 7 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr |
| Interest | 0.05 Cr | 0.13 Cr | 0.05 Cr | 0.07 Cr | 0.23 Cr | 0.67 Cr | 0.92 Cr | 0.64 Cr | 4 Cr | 4 Cr |
| Depreciation | 0.18 Cr | 0.28 Cr | 0.29 Cr | 0.56 Cr | 0.51 Cr | 0.77 Cr | 0.51 Cr | 0.77 Cr | 0.93 Cr | 1 Cr |
| Profit before tax | 3 Cr | 0.08 Cr | 0.21 Cr | 0.12 Cr | 2 Cr | 10 Cr | 17 Cr | 21 Cr | -2 Cr | 8 Cr |
| Tax % | 6.1% | 253.9% | -39.5% | 336.3% | 27.6% | 50.8% | 19.5% | 9.2% | -214.5% | 51.6% |
| Net profit | 3 Cr | -0.12 Cr | 0.29 Cr | -0.29 Cr | 1 Cr | 5 Cr | 14 Cr | 19 Cr | -7 Cr | 4 Cr |
| EPS (₹) | ₹0.65 | ₹0.16 | ₹0.05 | ₹-0.05 | ₹0.09 | ₹0.77 | ₹2.15 | ₹0.30 | ₹-0.11 | ₹0.06 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 21 Cr | 111 Cr | 309 Cr | Sign in for TTM |
| Operating expenses (approx.) | 19 Cr | 107 Cr | 265 Cr | Sign in for TTM |
| EBITDA | 2 Cr | 3 Cr | 43 Cr | Sign in for TTM |
| OPM % | 8.9% | 3.0% | 14.0% | Sign in for TTM |
| Other income | 0.50 Cr | 1 Cr | 12 Cr | Sign in for TTM |
| Interest | 0.07 Cr | 0.47 Cr | 6 Cr | Sign in for TTM |
| Depreciation | 0.18 Cr | 2 Cr | 3 Cr | Sign in for TTM |
| Profit before tax | 2 Cr | 2 Cr | 46 Cr | Sign in for TTM |
| Tax % | 12.9% | 45.7% | 33.1% | Sign in for TTM |
| Net profit | 2 Cr | 1 Cr | 31 Cr | Sign in for TTM |
| EPS (₹) | ₹1.67 | ₹0.22 | ₹0.48 | Sign in for TTM |
| Dividend payout % | 0.0% | 0.0% | 0.9% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 54 Cr | 64 Cr | 65 Cr |
| Reserves | 28 Cr | 274 Cr | 319 Cr |
| Borrowings | 2 Cr | 60 Cr | 72 Cr |
| Other liabilities | 4 Cr | 59 Cr | 214 Cr |
| Total liabilities | 86 Cr | 457 Cr | 671 Cr |
| Fixed assets (net) | 9 Cr | 14 Cr | 12 Cr |
| CWIP | — | 1 Cr | 3 Cr |
| Investments | 1 Cr | 11 Cr | 118 Cr |
| Inventories | 4 Cr | 9 Cr | 13 Cr |
| Trade receivables | 23 Cr | 76 Cr | 289 Cr |
| Cash & bank | 0.95 Cr | 104 Cr | 12 Cr |
| Other assets | 47 Cr | 242 Cr | 225 Cr |
| Total assets | 86 Cr | 457 Cr | 671 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operating activity | -7 Cr | -86 Cr | -101 Cr |
| Cash from investing | -31 Cr | -125 Cr | -5 Cr |
| Cash from financing | 37 Cr | 315 Cr | 14 Cr |
| Net cash flow | -2 Cr | 103 Cr | -92 Cr |
| Free cash flow (OCF − Capex) | -8 Cr | -92 Cr | -103 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | 2.6% | 0.7% | 11.4% |
| ROE % | 2.3% | 0.4% | 8.1% |
| Debtor days | 398 | 250 | 341 |
| Inventory days | 104 | 30 | 74 |
| Days payable | 50 | 68 | 600 |
| Cash conversion cycle | 452 | 212 | -185 |
| Debt / equity | 0.02 | 0.18 | 0.19 |
| Current ratio | 18.42 | 4.48 | 1.62 |
| Net debt / EBITDA | 0.39 | -13.22 | 1.40 |
Compare with peers
Loading peers…